1.4K
Articles
50.1K
Citations
4.2
avg. Impact Factor
104
h-index

Most Cited Articles of Harvard Medical School in 2011

TitleJournalYearCitations
Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathyCirculation2011251
Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillationCirculation: Arrhythmia and Electrophysiology2011219
Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studiesClinical Pharmacology and Therapeutics2011217
Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutationJournal of Clinical Investigation2011178
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillationEuropace2011147
Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increaseCirculation2011123
20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathwaysJournal of Cardiovascular Pharmacology201194
RhoJ is an endothelial cell-restricted Rho GTPase that mediates vascular morphogenesis and is regulated by the transcription factor ERGBlood201162
Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysisJournal of Thrombosis and Haemostasis201161
Inhibition of c-Src tyrosine kinase prevents angiotensin II-mediated connexin-43 remodeling and sudden cardiac deathJournal of the American College of Cardiology201155
Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studiesJournal of Pharmaceutical and Biomedical Analysis201148
Patterns of baseline autonomic nerve activity and the development of pacing-induced sustained atrial fibrillationHeart Rhythm201147
PTPN11-associated mutations in the heart: has LEOPARD changed Its RASpots?Trends in Cardiovascular Medicine201139
Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: a meta-analysis of randomized studiesQJM - Monthly Journal of the Association of Physicians201133
Inhibition of renin-angiotensin system (RAS) reduces ventricular tachycardia risk by altering connexin43Journal of Molecular Medicine201124
In vitro and in vivo degradation of poly(D, L-lactide-co-glycolide)/amorphous calcium phosphate copolymer coated on metal stentsJournal of Biomedical Materials Research - Part A201122
Complications of atrial fibrillation ablation: when prevention is better than cureEuropace201118
Can benign etiologies predict benign outcomes in high-risk syncope patients?Journal of Emergency Medicine201112
Atrial fibrillation: an epidemic in the elderlyExpert Review of Cardiovascular Therapy201112
The SYNTAX score: usefulness, limitations, and future directionsJournal of Invasive Cardiology201111
Resveratrol supplementation abrogates pro-arteriogenic effects of intramyocardial vascular endothelial growth factor in a hypercholesterolemic swine model of chronic ischemiaSurgery201110
CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson's diseaseJournal of Neural Transmission20119
Autologous cardiomyotissue implantation promotes myocardial regeneration, decreases infarct size, and improves left ventricular functionCirculation20117
Saying yes to exercise and NO to cardiac injuryCirculation Research20117
Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-siteAmerican Heart Journal20113